Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Bluebird bio, Inc. is a biotechnology company specializing in developing and commercializing gene therapies for severe genetic diseases. Its core focus is on innovative lentiviral vector-based treatments for conditions like sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy. The company’s products aim to provide lifelong cures through one-time treatments, leveraging proprietary technology, extensive clinical data, and a specialized treatment center network.
This description was generated via AI from an annual report. Updated about 1 year ago.